Research Paper Volume 14, Issue 11 pp 4739—4754
A novel immune-related microRNA signature for prognosis of thymoma
Figure 5. Time-dependent ROC illustrating the accuracy of Masaoka stage, BRRS, and CRS for predicting the RFS at 3 years (A) and 5 years (B). (n = 120 THYM samples).